Predictions
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.58
04.12.20
04.12.20
-
04.12.21
04.12.21
282.12%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Krystal Biotech
Start price
Target price
Perf. (%)
€42.60
30.10.21
30.10.21
€37.00
30.11.22
30.11.22
54.93%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€11.84
13.09.21
13.09.21
-
13.09.22
13.09.22
139.19%
29.11.21
29.11.21
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.50
22.11.21
22.11.21
-
22.11.22
22.11.22
-2.83%
28.11.21
28.11.21
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€6.92
10.07.21
10.07.21
€5.80
10.07.22
10.07.22
-6.86%
27.11.21
27.11.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.97
15.11.21
15.11.21
-
15.11.22
15.11.22
-28.16%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Boiron S.A.
Start price
Target price
Perf. (%)
€38.55
13.04.21
13.04.21
€36.00
13.04.22
13.04.22
-1.30%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€20.60
17.06.21
17.06.21
€17.00
17.06.22
17.06.22
38.84%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.80
17.10.21
17.10.21
€25.00
17.10.22
17.10.22
-15.53%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.38
25.11.21
25.11.21
€21.00
25.11.22
25.11.22
6.64%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Poxel S.A.
Start price
Target price
Perf. (%)
€5.86
07.10.21
07.10.21
€7.50
07.10.22
07.10.22
-8.28%
24.11.21
24.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
17.11.21
17.11.21
€1.80
17.11.22
17.11.22
0.00%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€148.30
04.10.21
04.10.21
-
04.10.22
04.10.22
2.14%
15.11.21
15.11.21
Could be worthwhile Investment >10% per year
Some uniques
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Novavax Inc.
Start price
Target price
Perf. (%)
€117.42
20.10.21
20.10.21
€105.00
20.10.22
20.10.22
24.32%
11.11.21
11.11.21
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Virbac S.A.
Start price
Target price
Perf. (%)
€395.50
25.10.21
25.10.21
€480.00
25.10.22
25.10.22
1.52%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year
Omeros Corp.
Start price
Target price
Perf. (%)
€5.21
19.10.21
19.10.21
-
19.10.22
19.10.22
19.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Deciphera Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.09.21
29.09.21
€40.00
31.12.24
31.12.24
-67.96%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year